Minireviews
Copyright ©The Author(s) 2018.
World J Gastroenterol. May 14, 2018; 24(18): 1978-1988
Published online May 14, 2018. doi: 10.3748/wjg.v24.i18.1978
Table 2 Systematic review of laparoscopic gastrojejunostomy for gastrict obstruction due to advanced hepatobiliary cancer
Ref.nType of studyHPB EtiologyBiliary obstructionOperating timePerioperative morbidityTime to initiate intakeTime to solid foodLOSDuration of food intakeComment
All HPB Malignancy
Jeurnink et al[60], 200795Cohort: GJ (42) vs duodenal stent (53)GJ: All patients (laparoscopy: 10)GJ: 17 previous treatmentNDGJ: 4 major (hemorrhage, severe pain, cholangitis, respiratory failure); 13 minor (mild pain, wound infection, nausea and vomiting)NDGJ: 10.1 ± 4.8 dGJ: 18d (4-55)ND
Hamade et al[4], 200521Cohort: laparoscopic GJ/CJ/GJ+CJAll patients5 biliary bypass, 8 GJ+biliary bypassgastric bypass 75 min, GJ+CJ 130 min1 pneumonia, 1 central line sepsis, 1 wound abscessNDND4 d (1-14)9 patients untill deathIncludes pre-treatment, profilactic and terapeutic GJ
Denley et al[9], 200518Case series: LGJAll patientsNDND2 reconversions, 1 leak, 1 sepsis, 1 DGENDND6 (3-22)15 patients untill death
Kazanjian et al[5], 20049Case series: LGJAll patientsND116 min (75-300)1 DGE, 1 CholangitisND4 d (3-6)7 d (5-18)ND4 patient previous stent
Alam et al[61], 20038Case series: LGJAll patientsND135 minPneumonia (1)ND4 (2-7)7 (5-13)7 patients untill death
Kuriansky et al[62], 200012Case series: LGJ+biliary bypassAll patients12 CCJ89.16 min (35-150)2 wound infection, 1 pneumonia, 2 DGE, 1 reintervention (bleeding)NDND6.4 (5-17)All patients untill death
Casaccia et al[63], 19996Case series: LGJAll patients4 ES. 2 Laparoscopic CCJ82 min (60-135)1 Bleeding (transfusion)NDND4.5 (4-6)ND
Casaccia et al[64], 19985Case series: LGJAll patients4 ES. 1 laparoscopic CCJND1 Bleeding (transfusion)NDND4 (4-6)ND
Rhodes et al[65], 199516Case series: laparoscopic CCJ ± GJ (5GJ, 3 both, 9CCJ)All patientsND75 min1 DGE, 1 ictusNDND4 d (3-33)NDResults of the entire data series
Wilson et al[57], 19922Case series: LGJAll patientsND120 minNone2d3 d, 4 d4-5 d1 patient untill death
Mixed malignancies
Zhang et al[66], 201128Case series: LGJ for benign/malignant disease7 HPB malignancyND170 min2 reinterventions (anastomotic leak, trocar site hemorrhage), 2 bleeding controlled by endoscopy, 1 ileus, 5 DGE3d5 d8 d (2-83)NDResults of the entire data series
Guzman et al[3], 200920Cohort: LGJ AND OGJLaparoscopy: 8 HPB malignancyND116 min2 DGEND7 d8 dND
Navarra et al[67], 200624RCT: 12 LGJ vs 12 OGJLaparoscopy: 5 HPB malignancyND150 minNoneND4.08 d11 dND
Mehta et al[39], 200627RCT: 14 LGJ vs 13 SEMSND6 patients (ES, PD)ND2 bleeding, 1 wound infection, 1 pneumonia, 3 DGE. 3 mortality (sepsis, pneumonia, carcinomatosis)NDND11.4 DND
Al-Rashedy et al[68], 200526Cohort: LGJ and OGJLaparoscopy: 7 HPB malignancyNDND2 (13.3%)NDND3 (3-8)ND
Khan et al[69], 200519Case series: laparoscopic CCJ ± GJ (16 GJ, 1 CCJ, 2 both)7 HPB malignancy2 CCJ164 min single bypass, 245 min double bypassND3dNDNDND
Mittal et al[37], 200456Cohort: 16 OGJ, 14 LGJ, 16 ES.Laparoscopy: 9 HPB malignancyNone patientND4 pneumonia, 1 ileus, 1 wound infectionND5 d (4-8)13.5 d (6-36) (after procedure 7d)ND
Bergamaschi et al[70], 200255Case/control: antiperistaltic vs isoperistaltic LGJAP-LGJ: 29 HPB malignancy, IP-LGJ 14 HPB malignancyND100min (AP) vs 99min (IP)14 (II: 1, III: 9, IV: 3)ND5.1d (AP) vs 5.3 d (IP)8.4 d (AP) vs 8.1 d (IP)ND
Bergamaschi et al[71],199822Case /control: OGJ (prophylactic and GOO treatment) vs LGJ (GOO treatment)Laparoscopy: 9 HPB malignancy1 ES, 3 PD94 minPneumonia (1), SSI (1), delayed gastric emptying (1)ND8.4 (media)18.4 (media)ND
Brune et al[15], 199716Case series: LGJ13 HPB malignancyES/PD126 min (70-210)1 reintervention (hemorrhage), 3 delayed gastric emptyingNDND4.7 (2-8)16 patients untill death
Nagy et al[72], 199510Case series: LGJ9 HPB malignancy8 ES/1 PD/ 2 simultaneous CJND2 reconversions, 1 CCF, 1 pneumonia, 1 CD infectionND10 d (4-15)NDAll patients untill death